Friday, January 31, 2025

X-CIPLOG 2025 Reunion and Awards reflects industry excellence, resonates with Government Padma honour to Pharma industry


Delighted by the grand reunion, Cipla Veteran M.K. Hamied acknowledged the lasting bond and contributions of Cipla’s former employees. Expressing gratitude, he emphasized that Cipla’s current success is a testament to their collective efforts and dedication over the years.

The 6th X-CIPLOG Reunion Event 2025, held in Worli, Mumbai, celebrated the achievements of 12 distinguished professionals and three pharma institutions of international repute – Cipla, Serum and Zydus, from the pharmaceutical industry. Organized by Ex-Cipla employees, an association of over 500 ex-employees, the event honoured exemplary contributions and fostered industry-wide collaboration, innovation, and camaraderie.

Delighted by the grand reunion, Cipla Veteran M.K. Hamied acknowledged the lasting bond and contributions of Cipla’s former employees. Expressing gratitude, he emphasized that Cipla’s current success is a testament to their collective efforts and dedication over the years.

Dr. Vinay Nayak, founder and chief mentor of the X-CIPLOG Group and chairman of the IDMA Technical Committee, underscored the importance of such gatherings. He emphasized how these events strengthen industry relationships and promote thought leadership among professionals.

The event featured several insightful sessions, including Motivational Tech-Talks on emerging digital technologies, including gummies technology for drug delivery, particularly for ayurvedic and nutraceuticals medicines.

It featured a discussion on working with multiple companies and fostering a culture of leadership and also work-life balance – An engaging panel discussion on post-50s fitness journeys, including marathons, cycling, trekking and nature walks to maintain cognitive agility.

The award ceremony highlighted Cipla’s breakthrough in drug delivery through inhalation. A major milestone was Cipla’s approval from the Central Drugs Standard Control Organization (CDSCO) for Afrezza, an inhalable insulin developed by MannKind. This innovative solution provides a non-injectable alternative for diabetes management, aligning with Cipla’s mission to enhance accessibility and patient care in India.

It featured Innovation and Career Excellence Awards 2025 which conferred Innovation Award 2025 – Pharmaceutical Organizations like Serum Institute of India recognized for its leadership and innovation in vaccine technology and Zydus Cadila honored in acknowledgment of Pankaj Patel receiving the Padma Bhushan award from the Government of India.

This was followed by Career Excellence Awards 2025 – Pharmaceutical Industries. Geena Malhotra was awarded for her contribution in R&D and Tech Services, Preetish Toraskar – Founder Director & CEO, Koye Pharma for Marketing and Entrepreneurship, Sanjay Shetgar for Quality Assurance, Rajesh Ghangurde for Export Management, Deepak Dhuri for Supply Chain Management, P.P. Ramchandran for Human Resources, Anil Kumar for Manufacturing, Pradeep Surve for Research & Development, Dr. Prashant Dikshit for Quality Assurance, Dr. Suhas Mangaonkar for Microbiology, Dr. T.G. Chandrashekar for Technical Services and Dr. Anil Pareek for Medical Services.

Each awardee was honored for their outstanding contributions to the pharmaceutical industry, reinforcing the vision of “Together We Can Keep the World Healthy.” The event was convened with the active organising team of Sandeep Mankame, Sachin Ghosalkar, Davinder Singh, S. G. Belapure, Ram Gulwady, Satyasheel Desai, Vijay Kumar Maroo, Rajesh Ghangurde, Gayatri Khedekar, Sanjeev Bhale, Reshama, Isha Chaurasia, Sonia and S. N. Salgaonkar.

A Coffee Table Book - SHILPIIY- was also unveiled during the Award Ceremony to showcase the biodiversity, intellectual property, socio-economic and cultural diversity of the hill state – Uttarakhand authored by Dr. B P Nautiyal and Shardul Nautiyal.

“The X-CIPLOG Reunion serves as a catalyst for fostering innovation, leadership, and lifelong learning process. The event concluded with a renewed commitment to driving advancements in pharmaceuticals and healthcare for a healthier future,” concluded Dr. Nayak. 

 







No comments: